• In February 2026, activist investor Impactive Capital escalated pressure on WEX Inc. by launching a proxy contest, nominating four directors and criticizing the company’s operating margins, governance, and long-term performance versus peer Corpay.
• This challenge comes after WEX completed a US$1.88 billion share repurchase program and reported higher quarterly earnings per share despite largely flat full-year net income, sharpening the focus on how capital has been deployed.
• We’ll now examine how Impactive Capital’s push for board change and sharper performance discipline could influence WEX’s existing investment narrative.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

WEX Investment Narrative Recap

To own WEX today, you have to believe its diversified payments, fleet, and benefits platform can still compound value despite competitive and regulatory pressures. In the near term, the key catalyst is whether management can translate its technology and sales investments into higher-quality growth and margins, while the biggest emerging risk is that the Impactive Capital proxy fight distracts leadership and complicates execution. The recent activism does not change the business model, but it may influence how aggressively it is managed.

The most relevant recent announcement is Impactive Capital’s February 2026 proxy contest, which directly targets WEX’s 2025 operating margin gap to Corpay and questions the board’s oversight of capital allocation, including the completed US$1.88 billion buyback. This board challenge now sits alongside product, EV, and healthcare catalysts as a near term event that could reshape priorities, cost discipline, and the pace of investment across WEX’s mobility, corporate payments, and benefits franchises.

Yet investors should also be aware that the biggest risk may not be what Impactive is saying, but how a prolonged proxy battle could...

WEX's narrative projects $3.0 billion revenue and $450.9 million earnings by 2028. This requires 4.9% yearly revenue growth and a $144.4 million earnings increase from $306.5 million today.

Uncover how WEX's forecasts yield a $173.60 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming revenue of about US$2.8 billion and earnings near US$376 million by 2028, and this activism plus rising competitive pressure on margins may reinforce that more pessimistic view, so you should recognize how differently people can see the same stock and compare these scenarios for yourself.

Explore 3 other fair value estimates on WEX - why the stock might be worth just $173.60!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your WEX research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free WEX research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate WEX's overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.